IVC Filter, a product aimed at preventing traveling blood clots from causing further damage to the body has been proven to have adverse effects leading them to be categorized as defective medical devices.
The defective medical devices, IVC Filters, are usually recommended to be used when different inconsistencies prevent or limit the use of blood thinners. An Inferior vena cava or IVC filter was created as a means to prevent ambulatory blood clots from traveling into the lung cavity. Its spider-like blueprint is implanted into a patient’s primary artery, the inferior vena cava and is meant to trap blood clots that travel through the lower extremities.
However, according to Dr. William Kuo, the head of the IVC Filter Clinic at Stanford Health Care, the IVC is a defective medical device that has done much more harm than good to those patients who have had the device implanted. The IVC filter has been known to splinter, and break apart inside the body. This defect makes it increasingly harder to surgically remove the device as the fractured pieces migrate within the body. One would think that such a horrible defect to an increasingly used product would lead to a major recall once it was uncovered, but sadly it seems the impending profit overrides the safety of patients implanted with the device.
According to a NBC News Investigation, C.R. Bard, the company responsible for manufacturing many IVC filters was well aware of the problems with the original IVC but refused to recall the device. The promise of increased revenue overweighed the impending danger for their patients.